ObsEva SA Ordinary Shares
OBSV
OBSV was delisted on the 22nd of March, 2023.
24 hedge funds and large institutions have $152M invested in ObsEva SA Ordinary Shares in 2017 Q1 according to their latest regulatory filings, with 24 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SMV
Sofinnova Management VIII
Menlo Park,
California
|
+$46.1M |
| 2 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$41M |
| 3 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$37.4M |
| 4 |
O
OrbiMed
New York
|
+$32M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$10.3M |
Top Sellers
OBSV Hedge Fund Activity: Q1 2017 in Review
24 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in ObsEva SA Ordinary Shares (OBSV) for Q1 2017, worth a combined $152M.
Buyers outnumbered sellers: 24 funds opened new OBSV positions and 0 closed out — a net gain of 24 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Sofinnova Management VIII, opening a new position worth an estimated $46.1M.
- 24 institutional investors held ObsEva SA Ordinary Shares (OBSV) as of Q1 2017, up from 0 in Q4 2016.
- Funds reported $152M of ObsEva SA Ordinary Shares stock for Q1 2017.
- 24 funds opened new ObsEva SA Ordinary Shares positions in Q1 2017 and 0 closed out, a net change of +24 holders.
- The largest ObsEva SA Ordinary Shares buyer in Q1 2017 was Sofinnova Management VIII, an estimated $46.1M added.
Based on aggregated 13F filings for Q1 2017.